BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8567337)

  • 1. Effect of cisplatin on the clinically relevant radiosensitivity of human cervical carcinoma cell lines.
    Britten RA; Evans AJ; Allalunis-Turner MJ; Pearcey RG
    Int J Radiat Oncol Biol Phys; 1996 Jan; 34(2):367-74. PubMed ID: 8567337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of an in vitro chemo-radiation response assay for cervical carcinoma.
    Monk BJ; Burger RA; Parker R; Radany EH; Redpath L; Fruehauf JP
    Gynecol Oncol; 2002 Nov; 87(2):193-9. PubMed ID: 12477451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential radiation sensitization of human cervical cancer cell lines by the proteasome inhibitor velcade (bortezomib, PS-341).
    Kamer S; Ren Q; Dicker AP
    Arch Gynecol Obstet; 2009 Jan; 279(1):41-6. PubMed ID: 18461345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of human tumour cell responses to cisplatin and ZD0473 with and without irradiation.
    Raaphorst GP; Yang DP; Li LF; Malone S
    Anticancer Res; 2004; 24(2B):613-8. PubMed ID: 15161002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Additive cytotoxic effect of cisplatin and X-irradiation on human glioma cell cultures derived from biopsy-tissue.
    Fehlauer F; Barten-Van Rijbroek AD; Stalpers LJ; Leenstra S; Lindeman J; Tjahja I; Troost D; Wolbers JG; van der Valk P; Sminia P
    J Cancer Res Clin Oncol; 2000 Dec; 126(12):711-6. PubMed ID: 11153144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of 41 degrees C and 43 degrees C on cisplatin radiosensitization in two human carcinoma cell lines with different sensitivities for cisplatin.
    Bergs JW; Haveman J; Ten Cate R; Medema JP; Franken NA; Van Bree C
    Oncol Rep; 2007 Jul; 18(1):219-26. PubMed ID: 17549371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paclitaxel is preferentially cytotoxic to human cervical tumor cells with low Raf-1 kinase activity: implications for paclitaxel-based chemoradiation regimens.
    Britten RA; Perdue S; Opoku J; Craighead P
    Radiother Oncol; 1998 Sep; 48(3):329-34. PubMed ID: 9925253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential application of the ATP cell viability assay in the measurement of intrinsic radiosensitivity in cervical cancer.
    Tam KF; Ng TY; Liu SS; Tsang PC; Kwong PW; Ngan HY
    Gynecol Oncol; 2005 Mar; 96(3):765-70. PubMed ID: 15721424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An interaction of cisplatin and radiation in two rat yolk sac tumour cell lines with different radiosensitivities in vitro.
    Nakamoto S; Mitsuhashi N; Takahashi T; Sakurai H; Niibe H
    Int J Radiat Biol; 1996 Dec; 70(6):747-53. PubMed ID: 8980672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation-induced cell death is independent of the apoptotic signals mediated by death-associated protein kinase in human cervical squamous cell carcinoma cells.
    Tanaka T; Bai T; Yukawa K; Umesaki N
    Oncol Rep; 2005 Oct; 14(4):949-55. PubMed ID: 16142356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the CXCL12/CXCR4 pathway and myeloid cells to improve radiation treatment of locally advanced cervical cancer.
    Lecavalier-Barsoum M; Chaudary N; Han K; Koritzinsky M; Hill R; Milosevic M
    Int J Cancer; 2018 Sep; 143(5):1017-1028. PubMed ID: 29417588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral platinum analogue JM216, a radiosensitizer in oxic murine cells.
    van de Vaart PJ; Klaren HM; Hofland I; Begg AC
    Int J Radiat Biol; 1997 Dec; 72(6):675-83. PubMed ID: 9416790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiosensitization of uterine cancer cell lines by cytotoxic agents.
    Nguyen HN; Sevin BU; Averette HE; Gottlieb C; Perras J; Donato D; Penalver M
    Gynecol Oncol; 1993 Jan; 48(1):16-22. PubMed ID: 8423017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of sorafenib on cisplatin-based chemoradiation in head and neck cancer cells.
    Möckelmann N; Rieckmann T; Busch CJ; Becker B; Gleißner L; Hoffer K; Omniczynski M; Steinmeister L; Laban S; Grénman R; Petersen C; Rothkamm K; Dikomey E; Knecht R; Kriegs M
    Oncotarget; 2016 Apr; 7(17):23542-51. PubMed ID: 27015558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro chemosensitivity of four new carcinoma of the cervix cell lines: relationship to radiosensitivity.
    Kelland LR; Tonkin KS
    Eur J Cancer Clin Oncol; 1989 Aug; 25(8):1211-8. PubMed ID: 2475347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisplatin-mediated radiosensitization of non-small cell lung cancer cells is stimulated by ATM inhibition.
    Toulany M; Mihatsch J; Holler M; Chaachouay H; Rodemann HP
    Radiother Oncol; 2014 May; 111(2):228-36. PubMed ID: 24857596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recovery from radiation damage in human squamous carcinoma of the cervix.
    Kelland LR; Steel GG
    Int J Radiat Biol; 1989 Jan; 55(1):119-27. PubMed ID: 2562968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical pharmacokinetic study of cisplatin in enhancing cervical cancer radiosensitivity].
    Lu JL; Yang F
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug; 26(8):1170-2. PubMed ID: 16939913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro toxicity of (191)Pt-labeled cisplatin to a human cervical carcinoma cell line (ME-180).
    Areberg J; Johnsson A; Wennerberg J
    Int J Radiat Oncol Biol Phys; 2000 Mar; 46(5):1275-80. PubMed ID: 10725641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced cell killing induced by the combination of radiation and the heat shock protein 90 inhibitor 17-allylamino-17- demethoxygeldanamycin: a multitarget approach to radiosensitization.
    Russell JS; Burgan W; Oswald KA; Camphausen K; Tofilon PJ
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3749-55. PubMed ID: 14506167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.